hemophila B

A $3.5M ‘bargain’? CSL’s hemophilia B drug sets new pricing benchmark, as gene therapy costs mount
Medical Marketing and Media
Thu, 12/1/22 - 10:34 am
CSL
Hemgenix
drug pricing
hemophila B
uniQure, CSL claim first okay for hemophilia B gene therapy
Pharmaphorum
Wed, 11/23/22 - 07:53 am
uniQure
CSL
hemophila B
gene therapy
Hemgenix
FDA
Sanofi revises fitusiran dosing to cut risk of thrombotic events in hemophilia phase 3
Fierce Biotech
Mon, 02/8/21 - 10:41 am
Sanofi
fitusiran
hemophilia
hemophilia A
hemophila B